OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
NEAT1_1 confers gefitinib resistance in lung adenocarcinoma through promoting AKR1C1-mediated ferroptosis defence
Shuman Zhen, Yunlong Jia, Yan Zhao, et al.
Cell Death Discovery (2024) Vol. 10, Iss. 1
Open Access | Times Cited: 9
Shuman Zhen, Yunlong Jia, Yan Zhao, et al.
Cell Death Discovery (2024) Vol. 10, Iss. 1
Open Access | Times Cited: 9
Showing 9 citing articles:
Epigenetic modification of ferroptosis by non-coding RNAs in cancer drug resistance
Hongquan Wang, Joshua S. Fleishman, Sihang Cheng, et al.
Molecular Cancer (2024) Vol. 23, Iss. 1
Open Access | Times Cited: 10
Hongquan Wang, Joshua S. Fleishman, Sihang Cheng, et al.
Molecular Cancer (2024) Vol. 23, Iss. 1
Open Access | Times Cited: 10
Ferroptosis and hepatocellular carcinoma: the emerging role of lncRNAs
Haoran Chen, Zhongyu Han, Junyan Su, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 6
Haoran Chen, Zhongyu Han, Junyan Su, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 6
Ferroptosis-related signaling pathways in cancer drug resistance
Yang Yang‐Hartwich, Simin Yu, Wanyao Liu, et al.
Cancer Drug Resistance (2025) Vol. 8, Iss. 1
Open Access
Yang Yang‐Hartwich, Simin Yu, Wanyao Liu, et al.
Cancer Drug Resistance (2025) Vol. 8, Iss. 1
Open Access
Downregulation of AATK enhances susceptibility to ferroptosis by promoting endosome recycling in gefitinib‐resistant lung cancer cells
Wei‐Chang Lee, Sin‐Hua Moi, Sheau‐Fang Yang, et al.
The Journal of Pathology (2025)
Closed Access
Wei‐Chang Lee, Sin‐Hua Moi, Sheau‐Fang Yang, et al.
The Journal of Pathology (2025)
Closed Access
On QSPR analysis of pulmonary cancer drugs using python-driven topological modeling
Huiling Qin, Mazhar Hussain, Muhammad Farhan Hanif, et al.
Scientific Reports (2025) Vol. 15, Iss. 1
Open Access
Huiling Qin, Mazhar Hussain, Muhammad Farhan Hanif, et al.
Scientific Reports (2025) Vol. 15, Iss. 1
Open Access
PCK2 induces gefitinib resistance by suppresses ferroptosis in non-small cell lung cancer
Tinghao Yan, Ni Zhang, Yong Li, et al.
Biochemical and Biophysical Research Communications (2024) Vol. 723, pp. 150200-150200
Closed Access | Times Cited: 1
Tinghao Yan, Ni Zhang, Yong Li, et al.
Biochemical and Biophysical Research Communications (2024) Vol. 723, pp. 150200-150200
Closed Access | Times Cited: 1
The multifaceted perspectives on the regulation of lncRNAs in hepatocellular carcinoma ferroptosis: from bench-to-bedside
Xin Jin, C. Huang, Yue Tian
Clinical and Experimental Medicine (2024) Vol. 24, Iss. 1
Open Access | Times Cited: 1
Xin Jin, C. Huang, Yue Tian
Clinical and Experimental Medicine (2024) Vol. 24, Iss. 1
Open Access | Times Cited: 1
FTO/m6A mediates miR-138-5p maturation and regulates gefitinib resistance of lung adenocarcinoma cells by miR-138-5p/LCN2 axis
Dongxiao Ding, Wenjun Shang, Ke Shi, et al.
BMC Cancer (2024) Vol. 24, Iss. 1
Open Access
Dongxiao Ding, Wenjun Shang, Ke Shi, et al.
BMC Cancer (2024) Vol. 24, Iss. 1
Open Access
High expression of SLC34A2 contributes to chemoresistance of non-small cell lung cancer against gefitinib: the critical role of miR-124-3p
Chao Tan, Li Zhang, Sai Chen, et al.
Mutation Research/Fundamental and Molecular Mechanisms of Mutagenesis (2024) Vol. 830, pp. 111894-111894
Closed Access
Chao Tan, Li Zhang, Sai Chen, et al.
Mutation Research/Fundamental and Molecular Mechanisms of Mutagenesis (2024) Vol. 830, pp. 111894-111894
Closed Access
